These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19157062)

  • 21. Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis.
    Huovinen M; Loikkanen J; Myllynen P; Vähäkangas KH
    Toxicol In Vitro; 2011 Aug; 25(5):1007-17. PubMed ID: 21457773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATM status confers sensitivity to arsenic cytotoxic effects.
    Menéndez D; Mora G; Salazar AM; Ostrosky-Wegman P
    Mutagenesis; 2001 Sep; 16(5):443-8. PubMed ID: 11507245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
    Qiao D; Gaitonde SV; Qi W; Martinez JD
    Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined pathway to simulate CDK-dependent phosphorylation and ARF-dependent stabilization for p53 transcriptional activity.
    Doi A; Nagasaki M; Ueno K; Matsuno H; Miyano S
    Genome Inform; 2006; 17(1):112-23. PubMed ID: 17503361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review).
    Smeenk L; Lohrum M
    Int J Oncol; 2010 Nov; 37(5):1061-70. PubMed ID: 20878053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures of cell replication in risk/safety assessment of xenobiotic-induced, nongenotoxic carcinogenesis.
    Jones HB; Eldridge SR; Butterworth BE; Foster JR
    Regul Toxicol Pharmacol; 1996 Apr; 23(2):117-27. PubMed ID: 8661330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tumor suppressor p53.
    Donehower LA; Bradley A
    Biochim Biophys Acta; 1993 Aug; 1155(2):181-205. PubMed ID: 8357826
    [No Abstract]   [Full Text] [Related]  

  • 28. Attenuation of BPDE-induced p53 accumulation by TPA is associated with a decrease in stability and phosphorylation of p53 and downregulation of NFkappaB activation: role of p38 MAP kinase.
    Mukherjee JJ; Sikka HC
    Carcinogenesis; 2006 Mar; 27(3):631-8. PubMed ID: 16244358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
    Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
    Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells.
    Wang Z; Qi Y; Chen Q; Yang D; Tang S; Jin X; Gao J; Fu J; Zhou Z; Wang J; Xiao X
    Toxicology; 2009 Feb; 256(1-2):1-6. PubMed ID: 19027820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
    Maqbool R; Lone SN; Ul Hussain M
    Biochem J; 2016 Oct; 473(20):3597-3610. PubMed ID: 27531966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for manipulating the p53 pathway in the treatment of human cancer.
    Hupp TR; Lane DP; Ball KL
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):1-17. PubMed ID: 11062053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis.
    Yamamoto M; Tsukamoto T; Sakai H; Shirai N; Ohgaki H; Furihata C; Donehower LA; Yoshida K; Tatematsu M
    Carcinogenesis; 2000 Oct; 21(10):1891-7. PubMed ID: 11023548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin, E6-AP, and their role in p53 inactivation.
    Scheffner M
    Pharmacol Ther; 1998 Jun; 78(3):129-39. PubMed ID: 9690814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53.
    Page A; Navarro M; Suarez-Cabrera C; Alameda JP; Casanova ML; Paramio JM; Bravo A; Ramirez A
    Oncotarget; 2016 Apr; 7(15):20902-18. PubMed ID: 26959115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cellular senescence by p53.
    Itahana K; Dimri G; Campisi J
    Eur J Biochem; 2001 May; 268(10):2784-91. PubMed ID: 11358493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
    Russell JL; Weaks RL; Berton TR; Johnson DG
    Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzo[a]pyrene induced p53-mediated cell cycle arrest, DNA repair, and apoptosis pathways in Chinese rare minnow (Gobiocypris rarus).
    Yuan L; Lv B; Zha J; Wang Z
    Environ Toxicol; 2017 Mar; 32(3):979-988. PubMed ID: 27323304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic mechanisms of the carcinogenic effects of xenobiotics and in vitro methods of their detection.
    Hofmanová J; Machala M; Kozubík A
    Folia Biol (Praha); 2000; 46(5):165-73. PubMed ID: 11055794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.